Chemoinformaics analysis of Kaempferide triglycoside
| Molecular Weight | 770.69 | nRot | 10 |
| Heavy Atom Molecular Weight | 728.354 | nRig | 36 |
| Exact Molecular Weight | 770.227 | nRing | 6 |
| Solubility: LogS | -3.129 | nHRing | 4 |
| Solubility: LogP | -1.37 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 96 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 54 | No. of Aromatic Carbocycles | 2 |
| nHetero | 20 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 34 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 20 | No. of Arom Bond | 17 |
| nHA | 20 | APOL | 100.825 |
| nHD | 11 | BPOL | 56.8907 |
| QED | 0.096 |
| Synth | 5.29 |
| Natural Product Likeliness | 1.821 |
| NR-PPAR-gamma | 0.923 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.991 |
| HIA | 0.984 |
| CACO-2 | -6.347 |
| MDCK | 0.000159503 |
| BBB | 0.347 |
| PPB | 0.69474 |
| VDSS | 0.535 |
| FU | 0.258211 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.022 |
| CYP2c19-inh | 0.006 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.226 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.151 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.002 |
| CL | 0.97 |
| T12 | 0.212 |
| hERG | 0.019 |
| Ames | 0.547 |
| ROA | 0.029 |
| SkinSen | 0.005 |
| Carcinogencity | 0.094 |
| EI | 0.004 |
| Respiratory | 0.005 |
| NR-Aromatase | 0.947 |
| Antiviral | Yes |
| Prediction | 0.772142 |